Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity-Reference-Cited by-同舟云学术

Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity

Published:2022-11 Issue:11 Volume:25 Page:105412
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Yoshida Akiho,Okamura Shinya,Torii Shiho,Komatsu Sayuri,Miyazato Paola,Sasaki Hitomi,Ueno Shiori,Suzuki Hidehiko,Kamitani Wataru,Ono Chikako,Matsuura Yoshiharu,Takekawa Shiro,Yamanishi Koichi,Ebina Hirotaka

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference45 articles.

1. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies;Baum;Science,2020

2. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase;Chen;Proc. Natl. Acad. Sci. USA.,2009

3. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 protein complex;Chen;PLoS Pathog.,2011

4. A single mutation at PB1 Residue 319 dramatically increases the safety of PR8 live attenuated influenza vaccine in a Murine model without compromising vaccine efficacy;Cox;J. Virol.,2015

5. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex;Decroly;PLoS Pathog.,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1mΨ influences the performance of various positive-stranded RNA virus-based replicons;Scientific Reports;2024-07-31

2. 1mΨ influences the performance of various positive-stranded RNA virus-based replicons;2024-06-03

3. WITHDRAWN: COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations;Life Sciences;2024-06

4. Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms;2024-04-26

5. Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms;2024-04-26